BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19457120)

  • 1. Cell entry strategy of clostridial neurotoxins.
    Binz T; Rummel A
    J Neurochem; 2009 Jun; 109(6):1584-95. PubMed ID: 19457120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S; Tepp WH; Scherf JM; Johnson EA
    PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins.
    Brunger AT; Jin R; Breidenbach MA
    Cell Mol Life Sci; 2008 Aug; 65(15):2296-306. PubMed ID: 18425411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entering neurons: botulinum toxins and synaptic vesicle recycling.
    Verderio C; Rossetto O; Grumelli C; Frassoni C; Montecucco C; Matteoli M
    EMBO Rep; 2006 Oct; 7(10):995-9. PubMed ID: 17016457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the tetanus toxin reveals pH-mediated domain dynamics.
    Masuyer G; Conrad J; Stenmark P
    EMBO Rep; 2017 Aug; 18(8):1306-1317. PubMed ID: 28645943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gangliosides as high affinity receptors for tetanus neurotoxin.
    Chen C; Fu Z; Kim JJ; Barbieri JT; Baldwin MR
    J Biol Chem; 2009 Sep; 284(39):26569-77. PubMed ID: 19602728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridial neurotoxins: structure-function led design of new therapeutics.
    Chaddock JA; Marks PM
    Cell Mol Life Sci; 2006 Mar; 63(5):540-51. PubMed ID: 16416025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications.
    Zhou K; Luo W; Liu T; Ni Y; Qin Z
    Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridial Neurotoxins in Synaptic Research.
    Fields RD
    Neuroscientist; 1998 Sep; 4(5):324-328. PubMed ID: 31467473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxins--from cell biology to biomedical applications.
    Johannes L; Römer W
    Nat Rev Microbiol; 2010 Feb; 8(2):105-16. PubMed ID: 20023663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeleton-modulating effectors of enteropathogenic and enterohaemorrhagic Escherichia coli: Tir, EspFU and actin pedestal assembly.
    Campellone KG
    FEBS J; 2010 Jun; 277(11):2390-402. PubMed ID: 20477869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperone-usher pathways: diversity and pilus assembly mechanism.
    Busch A; Waksman G
    Philos Trans R Soc Lond B Biol Sci; 2012 Apr; 367(1592):1112-22. PubMed ID: 22411982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Genotoxins: Merging the DNA Damage Response into Infection Biology.
    Grasso F; Frisan T
    Biomolecules; 2015 Aug; 5(3):1762-82. PubMed ID: 26270677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial antigenic variation mediated by homologous DNA recombination.
    Vink C; Rudenko G; Seifert HS
    FEMS Microbiol Rev; 2012 Sep; 36(5):917-48. PubMed ID: 22212019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of quinolone action and resistance.
    Aldred KJ; Kerns RJ; Osheroff N
    Biochemistry; 2014 Mar; 53(10):1565-74. PubMed ID: 24576155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, biological functions and applications of the AB5 toxins.
    Beddoe T; Paton AW; Le Nours J; Rossjohn J; Paton JC
    Trends Biochem Sci; 2010 Jul; 35(7):411-8. PubMed ID: 20202851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function Relationships Underlying the Capacity of Bordetella Adenylate Cyclase Toxin to Disarm Host Phagocytes.
    Novak J; Cerny O; Osickova A; Linhartova I; Masin J; Bumba L; Sebo P; Osicka R
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28946636
    [No Abstract]   [Full Text] [Related]  

  • 19. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.
    Seilie ES; Bubeck Wardenburg J
    Semin Cell Dev Biol; 2017 Dec; 72():101-116. PubMed ID: 28445785
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.